Tremfya 100 MG/ML one-pressml
Ended Awarded
- Contract number
- SPE2DB26FAUAP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,523
Award facts
- Contract value 100% obligated
- $11,523.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,523.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TREMFYA 100 mg/ml, a specialty pharmaceutical product. This firm fixed-price delivery order, awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The product will be delivered to Conshohocken, Pennsylvania, and is funded entirely by the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense medical facilities worldwide. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three optional 30-month periods. DMS Pharmaceutical Group serves as a critical regional prime vendor under this program, authorized to supply branded and generic prescription drugs, biologics, and medical consumables to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FAUAP?
SPE2DB26FAUAP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FAUAP worth?
The government has obligated $11,523 on SPE2DB26FAUAP.
Is contract SPE2DB26FAUAP an order under another contract?
Yes. SPE2DB26FAUAP is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FAUAP competed?
The extent of competition for SPE2DB26FAUAP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award